Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage

Annals of Hepatology

Volumn 11, Issue 5, 2012, Pages 667-671

  Mansour Ghanaei, Fariborz ^a   Mehrdad, Mojtaba ^b   Mortazavi, Sahereh ^b   Joukar, Farahnaz ^b   Khak, Mohammad ^c,d   Atrkar Roushan, Zahra ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Farzan Clinical Research Institute   (Iran)

Author keywords

Cirrhosis; Hypothyroidism; Thyroid dysfunction; Thyroid hormones

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CHILD PUGH SCORE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEPATITIS B; HEPATITIS C; HUMAN; LIOTHYRONINE BLOOD LEVEL; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NORMAL VALUE; SCORING SYSTEM; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 84865333699     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31440-1     Document Type: Article

References (25)

1. Sorvillo F, Mazziotti G, Carbone A, Morisco F, Cioffi M, Ro-tondi M, et al. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. Clin Endo-crinol (Oxf) 2003; 58: 207-212.
2. Kayacetin E, Kisakol G, Kaya A. Low serum total thyroxine and free triiodothyronine in patients with hepatic ence-phalopathy due to non-alcoholic cirrhosis. Swiss Med Wkly 2003; 5: 210-213.
3. Borzio M, Caldara R, Borzio F, Piepoli V, Rampini P, Ferrari C. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism. Gut 1983; 24: 631-636.
4. Bianchi GP, Zoli M, Marchesini G, Volta U, Vecchi F, Ierve-se T, et al. Thyroid gland size and function in patients with cirrhosis of the liver. Liver 1991; 11: 71-77.
5. Yamanaka T, Ido K, Kimura K, Saito T. Serum levels of thyroid hormones in liver diseases. Clin Chim Acta 1980; 14: 45-55.
6. Malik R, Hodgson H. The relationship between the thyroid gland and the liver. QJM 2002; 95: 559-569.
7. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, Zaer-Rezaii H, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis 2010; Suppl. 3: e113-e116.
8. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: A review article. J Res Med Sci 2009; 14: 249-258.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
10. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.
11. Laycock MA, Pascuzzi RM: The neuromuscular effects of hypothyroidism. Semin Neurol 1991; 11: 288-294.
12. Thobe N, Pilger P, Jones MP. Primary hypothyroidism masquerading as hepatic encephalopathy: case report and review of the literature. Postgrad Med J 2000; 76: 424-426.
13. Hegedus L. Decreased thyroid gland volume in alcoholic cirrhosis of the liver. J Clin Endocrinal Metab 1984; 106: 203-208.
14. Sanders JP, Van Der GS, Kaptein E, Darras VM, Kuhn ER, Leonard JL, et al. Characterization of a propylthiouracil-insensitive type I iodothyronine deiodinase. Endocrinology 1997; 138: 5153-5160.
15. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23: 38-89.
16. Tu HM, Legradi G, Bartha T, Salvatore D, Lechan RM, Lar-sen PR. Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. En-docrinol 1999; 140: 784-790.
17. Moustafa AH, Ali EM, Mohamed TM, Abdou HI. Oxidative stress and thyroid hormones in patients with liver diseases. Eur J Intern Med 2009; 20: 703-708.
18. De Groot LJ. Dangerous dogmas in medicine: the non-thyroidal illness syndrome. J Clin Endocrinol Metab 1999; 84: 151-164.
19. Kabadi UM, Premachandra BN. Serum T3 and reverse T3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver dysfunction. Am J Gastroenterol 1983; 78: 750-755.
20. Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Ple-bani M, et al. Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis. J Hepatol 1998; 28: 115-121.
21. Zietz B, Lock G, Plach B, Drobnik W, Grossmann J, Schölmerich J, et al. Dysfunction of the hypothalamic-pi-tuitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol 2003; 15: 495-501.
22. Huang MJ, Liaw YF. Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 1995; 10: 344-350.
23. Bruck R, Weiss S, Traister A, Zvibel I, Aeed H, Halpern Z, et al. Induced hypothyroidism accelerates the regression of liver fibrosis in rats. J Gastroenterol Hepatol 2007; 22: 2189-2194.
24. Oren R, Sikuler E, Wong F, Blendis LM, Halpern Z. The effects of hypothyroidism on liver status of cirrhotic patients. J Clin Gastroenterol 2000; 31: 162-163.
25. Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 1: 10-3.